Ciloxan for the management of corneal ulcers.
Bacterial keratitis (corneal ulcer) is a sight-threatening condition if not treated with the appropriate anti-infective agent. Treatment needs to be initiated with a broad-spectrum agent deemed to be most appropriate until culture results are obtained. If the suspected pathogen is staphylococci, streptococci, or Pseudomonas, Ciloxin is a new generation anti-infective agent considered highly effective against these pathogens.
A
A
Scott
D000328:Adult; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male
D002939:Ciprofloxacin